Mining on Alzheimer's diseases related knowledge graph to identity potential AD-related semantic triples for drug repurposing

Yi Nian, Xinyue Hu, Rui Zhang, Jingna Feng, Jingcheng Du, Fang Li, Larry Bu, Yuji Zhang, Yong Chen, Cui Tao

Abstract

Alzheimer’s Disease (AD) presents a significant global health challenge with limited therapeutic options. This paper details a computational framework that leverages literature mining and knowledge graphs (KGs) to identify existing substances—including drugs, chemicals, and dietary supplements—that may be repurposed for AD. By integrating semantic triple extraction from PubMed with advanced graph embedding techniques and BERT-based denoising, the researchers identified several high-probability candidates, many of which have been validated by subsequent clinical literature.

Introduction

Alzheimer’s Disease (AD) remains a global health crisis with no effective cure. Developing new drugs from scratch is an incredibly slow, expensive, and high-failure-rate process. Drug repurposing—finding new uses for already approved substances—offers a faster, safer alternative. However, the "knowledge bottleneck" is a significant hurdle: millions of biomedical research papers exist, and no human can synthesize every connection between disparate chemicals and neurodegenerative pathways. This research addresses the challenge of automatically mining this vast "dark data" to find hidden therapeutic links that researchers might have missed.

Methodology

The authors developed a multi-stage pipeline to transform unstructured biomedical text into a searchable, predictive map of medical knowledge.

  1. Extraction and Normalization: The team extracted over 113 million "semantic triples" (e.g., Drug A — treats — Disease B) from SemMedDB, a database derived from PubMed abstracts. They utilized the Unified Medical Language System (UMLS) to normalize medical terms and the Integrated Dietary Supplement Knowledge Base (iDISK) to categorize supplements.
  2. Denoising with BERT: To ensure data quality, the researchers employed a two-step filtering process. After initial rule-based filtering to remove generic concepts, they fine-tuned a PubMedBERT classifier on ~6,000 manually labeled triples. This step verified if the extracted triples were accurately supported by their original source sentences.
  3. Knowledge Graph Completion: The resulting graph was analyzed using three embedding algorithms: TransE, DistMult, and ComplEx. These models project entities into a vector space, allowing the system to predict missing links (potential new drug-disease pairs) based on the geometric distance between entities.
  4. Evaluation: To validate the model's predictive power, the authors used a "time-slicing" approach, training the model on data published before 2019 and testing its ability to predict findings that only appeared in literature published after that date.

Results and Model Performance

The evaluation revealed that simpler models often outperformed more complex ones in this specific biomedical context. TransE, a translational model, achieved the best results, suggesting that the geometric relationship between entities is a powerful signal for biomedical knowledge graphs.

Table 1: Performance comparison of knowledge graph embedding models across various metrics.

As shown in the performance table, TransE achieved a Mean Rank (MR) of 10.53 and a Hits@10 of 0.58, indicating that the correct therapeutic relationship appeared in the model's top 10 suggestions 58% of the time.

Beyond performance metrics, the model identified several high-probability candidates for AD repurposing. Notable drug candidates included Valacyclovir (an antiviral) and Prednisolone (a steroid). In the category of chemicals, Amifostine—typically used in cancer therapy—emerged as a top-ranked candidate for AD prevention. The study also highlighted the role of lifestyle factors, identifying dietary fiber, tea, and honey as having significant "affect" relationships with AD progression.

Table 2: Top-ranked drug and chemical candidates identified by the model for the treatment and prevention of Alzheimer’s Disease.

Validation against recent literature confirmed the framework's efficacy: supporting evidence was found for 7 out of 10 drug predictions and 8 out of 10 chemical predictions.

Discussion and Future Work

One of the key insights of this study is the essential role of the "BERT filter." Raw NLP-extracted data is inherently noisy; using a transformer-based model like PubMedBERT to calibrate the graph significantly improved the reliability of the resulting predictions. Furthermore, by explicitly including dietary supplements and chemicals, the framework acknowledges that AD management often involves a combination of clinical and lifestyle interventions.

Despite these successes, limitations remain. Computational constraints limited the final graph to 2.8 million triples out of the 113 million available. Future work will focus on scaling the model to incorporate more data and investigating embedding strategies that better handle "one-to-many" relationships, such as a single drug affecting multiple biological pathways. Additionally, the researchers aim to refine the detection of specific relationship types, moving from general "affect" links to more precise "treat" or "prevent" classifications for dietary supplements.

Summary updated

Abstract

Background To date, there are no effective treatments for most neurodegenerative diseases. Knowledge graphs can provide comprehensive and semantic representation for heterogeneous data, and have been successfully leveraged in many biomedical applications including drug repurposing. Our objective is to construct a knowledge graph from literature to study the relations between Alzheimer’s disease (AD) and chemicals, drugs and dietary supplements in order to identify opportunities to prevent or delay neurodegenerative progression. We collected biomedical annotations and extracted their relations using SemRep via SemMedDB. We used both a BERT-based classifier and rule-based methods during data preprocessing to exclude noise while preserving most AD-related semantic triples. The 1,672,110 filtered triples were used to train with knowledge graph completion algorithms (i.e., TransE, DistMult, and ComplEx) to predict candidates that might be helpful for AD treatment or prevention. Results Among three knowledge graph completion models, TransE outperformed the other two (MR = 10.53, Hits@1 = 0.28). We leveraged the time-slicing technique to further evaluate the prediction results. We found supporting evidence for most highly ranked candidates predicted by our model which indicates that our approach can inform reliable new knowledge. Conclusion This paper shows that our graph mining model can predict reliable new relationships between AD and other entities (i.e., dietary supplements, chemicals, and drugs). The knowledge graph constructed can facilitate data-driven knowledge discoveries and the generation of novel hypotheses.
BibTeX
@article{nian2022mining,
  author = {Yi Nian and Xinyue Hu and Rui Zhang and Jingna Feng and Jingcheng Du and Fang Li and Larry Bu and Yuji Zhang and Yong Chen and Cui Tao},
  title = {{Mining on Alzheimer's diseases related knowledge graph to identity potential AD-related semantic triples for drug repurposing}},
  journal = {BMC Bioinformatics},
  year = {2022},
  doi = {10.1186/s12859-022-04934-1},
}
Figure